Eli Lilly and Company (LLY)

Index:

S&P 100

$ 1,041.51
   
  • Change Today:
    $-38.85
  • 52 Week High: $1,109.94
  • 52 Week Low: $625.65
  • Currency: US Dollars
  • Shares Issued: 948.17m
  • Volume: 4,084,836
  • Market Cap: $987,528m
  • RiskGrade: 179
  • Beta: 0.69

Latest ShareCast News

Lilly reports solid results from new weight-loss drug trial

By Josh White

Date: Thursday 11 Dec 2025

(Sharecast News) - Eli Lilly reported the first successful phase three results for retatrutide, its experimental once-weekly 'triple agonist' drug, showing unprecedented weight loss alongside major improvements in knee osteoarthritis pain.

Eli Lilly posts stronger-than-expected Q3 earnings

By Iain Gilbert

Date: Thursday 30 Oct 2025

(Sharecast News) - Pharmaceutical giant Eli Lilly posted stronger-than-expected third-quarter earnings and revenue on Thursday, fuelled by surging demand for its diabetes drug Mounjaro and weight-loss treatment Zepbound.

Shares in Novo Nordisk slide as Trump targets obesity jabs

By Abigail Townsend

Date: Friday 17 Oct 2025

(Sharecast News) - Shares in Novo Norodisk slumped on Friday, after Donald Trump warned he would cut the price of the Danish firm's blockbuster weight-loss jabs.

Pfizer to acquire weight-loss start-up Metsera i... 22-Sep-2025 ShareCast
Trump warns pharma and chip tariffs possible fro... 16-Jul-2025 ShareCast
GSK, AstraZeneca slide after FDA unveils new vac... 07-May-2025 ShareCast
Lilly shares jump on positive results from oral ... 17-Apr-2025 ShareCast
Weight-loss drugs swell revenues at Eli Lilly 06-Feb-2025 ShareCast
Eli Lilly weight-loss drug Zepbound beats Wegovy... 04-Dec-2024 ShareCast
Eli Lilly's quarterly numbers disappoint, shares... 30-Oct-2024 ShareCast
Eli Lilly hikes guidance as obesity drug sales s... 08-Aug-2024 ShareCast
Eli Lilly hikes guidance as obesity drug sales s... 08-Aug-2024 ShareCast
Eli Lilly to acquire Morphic via tender offer 08-Jul-2024 ShareCast
Roche sees positive results from weight-loss tri... 16-May-2024 ShareCast
Eli Lilly hikes sales guidance by $2bn, shares j... 30-Apr-2024 ShareCast
Eli Lilly weight-loss drug 'significantly' reduc... 17-Apr-2024 ShareCast
Eli Lilly to buy Point Biopharma in $1.4bn deal 03-Oct-2023 ShareCast
Eli Lilly hikes guidance despite first-quarter e... 27-Apr-2023 ShareCast
Eli Lilly to buy genetic medicine developer Akou... 18-Oct-2022 ShareCast
Eli Lilly misses Q3 estimates, but sales top exp... 26-Oct-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 1,041.51
Change Today $ -38.85
% Change -3.60 %
52 Week High $1,109.94
52 Week Low $625.65
Volume 4,084,836
Shares Issued 948.17m
Market Cap $987,528m
Beta 0.69
RiskGrade 179

What The Brokers Say

Strong Buy 12
Buy 12
Neutral 7
Sell 0
Strong Sell 0
Total 31
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 05-Jan-2026

Time Volume / Share Price
15:59 40 @ $1,041.77
15:59 40 @ $1,041.74
15:59 40 @ $1,041.74
15:59 40 @ $1,041.65
15:59 40 @ $1,041.65

Top of Page